Aptargroup (ATR) Income from Non-Controlling Interests (2009 - 2026)
Aptargroup's (ATR) quarterly Income from Non-Controlling Interests came in at $89000.0 in Q1 2026, up 168.46% on a QoQ basis from -$130000.0 in Q4 2025.
Aptargroup (ATR) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Income from Non-Controlling Interests data on file, last reported at $89000.0 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to $89000.0 in Q1 2026; TTM through Mar 2026 was $18000.0, a 115.93% increase from a year earlier, with the FY2025 full-year figure at -$206000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $89000.0, up from -$130000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for ATR reached as high as $398000.0 in Q4 2022 and fell as low as -$178000.0 in Q1 2023.
- Historically, Income from Non-Controlling Interests has averaged $66.67 across 5 years, with a median of -$12000.0 in 2022.
- Across the five-year window, Income from Non-Controlling Interests soared 610.26% in 2022 and slumped 5950.0% in 2024, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $398000.0 in 2022, then slumped by 49.5% to $201000.0 in 2023, then slumped by 158.21% to -$117000.0 in 2024, then slipped by 11.11% to -$130000.0 in 2025, then soared by 168.46% to $89000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $89000.0 in Q1 2026, -$130000.0 in Q4 2025, and $47000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -18.70 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | - |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 110.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | - |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | - |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | - |
| 10 | Aptargroup | 8.56 Bn | 8.33 Bn | 351.91 Mn | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | -130,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Sep 30, 2024 | -117,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Mar 31, 2024 | -171,000.00 |
| Dec 31, 2023 | 201,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -178,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Sep 30, 2022 | -67,000.00 |
| Jun 30, 2022 | -12,000.00 |
| Mar 31, 2022 | -52,000.00 |
| Dec 31, 2021 | -78,000.00 |
| Sep 30, 2021 | -366,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Dec 31, 2020 | 13,000.00 |